SIMEPREVIR PLUS PEGINTERFERON/RIBAVIRIN COST-EFFECTIVENESS ANALYSIS FOR THE TREATMENT OF CHRONIC GENOTYPE 1 HEPATITIS C IN MEXICO

被引：0
|
作者：
Heibeck, V [1 ]
Westerhout, K. Y. [2 ]
Naciben, V [3 ]
Gasca-Pineda, R. [4 ]
Hernandez-Garduno, A. [5 ]
Chacon-Ramos, C. [4 ]
机构：
[1] Pharmerit Int, Berlin, Germany
[2] Pharmerit Int, Rotterdam, Netherlands
[3] Janssen Pharmaceut, Sao Paulo, Brazil
[4] Janssen Pharmaceut, Mexico City, DF, Mexico
[5] Janssen, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.018
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PIN24
引用
收藏
页码：A872 / A872
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection
    Saab, S.
    Gordon, S. C.
    Park, H.
    Sulkowski, M.
    Ahmed, A.
    Younossi, Z.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (06) : 657 - 675
  • [2] Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naive chronic hepatitis C genotype 1 patients in Japan
    Kuwabara, Hiroyo
    Westerhout, Kirsten
    Treur, Maarten
    Cerri, Karin
    Mahlich, Joerg
    Yatsuhashi, Hiroshi
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (07) : 502 - 511
  • [3] Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment
    Blatt, Carine Raquel
    Storb, Bernd
    Muehlberger, Nikolai
    Farias, Mareni Rocha
    Siebert, Uwe
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 50 (02) : 345 - 352
  • [4] A cost-effectiveness analysis of peginterferon alfa-2b plus ribavirin for the treatment of naive patients with chronic hepatitis C
    Buti, M
    Medina, M
    Casado, MA
    Wong, JB
    Fosbrook, L
    Esteban, R
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (05) : 687 - 694
  • [5] Cost-effectiveness of peginterferon α-2b plus ribavirin treatment of chronic hepatitis C with F1 fibrosis
    Wong, JB
    Poynard, T
    Manns, MP
    McHutchison, JG
    Harvey, J
    Albrecht, JK
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A718 - A718
  • [6] COST-EFFECTIVENESS OF TELAPREVIR PLUS PEGINTERFERON/RIBAVIRIN (TVR plus PR) VERSUS PEGINTERFERON/RIBAVIRIN (PR) IN TREATMENT-NAIVE GENOTYPE 1 CHRONIC HEPATITIS C PATIENTS WITH F2 FIBROSIS IN BRAZIL
    Morais, A. D.
    Pereira, M. L.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A354 - A354
  • [7] COST-EFFECTIVENESS OF BOCEPREVIR USE IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE-1 WHO FAILED PRIOR TREATMENT WITH PEGINTERFERON/RIBAVIRIN
    Chhatwal, Jagpreet
    Ferrante, Shannon A.
    Dasbach, Erik J.
    El Khoury, Antoine
    Brass, Clifford A.
    Burroughs, Margaret
    Bacon, Bruce R.
    Esteban, Rafael
    Elbasha, Elamin
    [J]. HEPATOLOGY, 2011, 54 : 801A - 802A
  • [8] Comparison of simeprevir plus peginterferon/ribavirin and telaprevir plus peginterferon/ribavirin for patients with HCV Genotype 1
    Nakajima, Tomoaki
    Kimura, Mutuumi
    Arakawa, Tomohiro
    Kuwata, Yasuaki
    Ozeki, Itaru
    Sato, Takahiro
    Ohmura, Takumi
    Hige, Shuhei
    Karino, Yoshiyasu
    Toyota, Joji
    [J]. HEPATOLOGY, 2013, 58 : 1140A - 1141A
  • [9] Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection
    Zeuzem, Stefan
    Hezode, Christophe
    Bronowicki, Jean-Pierre
    Loustaud-Ratti, Veronique
    Gea, Francisco
    Buti, Maria
    Olveira, Antonio
    Banyai, Tivadar
    Al-Assi, M. Tarek
    Petersen, Joerg
    Thabut, Dominique
    Gadano, Adrian
    Pruitt, Ronald
    Makara, Mihaly
    Bourliere, Marc
    Pol, Stanislas
    Beumont-Mauviel, Maria
    Ouwerkerk-Mahadevan, Sivi
    Picchio, Gaston
    Bifano, Marc
    McPhee, Fiona
    Boparai, Navdeep
    Cheung, Kin
    Hughes, Eric A.
    Noviello, Stephanie
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 (02) : 292 - 300
  • [10] COST EFFECTIVENESS OF BOCEPREVIR PLUS PEGINTERFERON ALPHA AND RIBAVIRIN VERSUS TELAPREVIR PLUS PEGINTERFERON ALFA AND RIBAVIRIN IN THE TREATMENT OF CHRONIC HEPATITIS C (CHC) IN PREVIOUSLY UNTREATED GENOTYPE I PATIENTS
    Fonseca, M.
    Garran, V
    Araujo, G. T.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A328 - A328
12345